Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / D3 Bio

D3 Bio

Series BUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$108Msum of rounds with a disclosed amount only
Named investors
5
Financing history
1 rounds
  1. Dec 9, 2025
    Series B · $108M (disclosed)
    IDG Vc Management Ltd. (participant)SongQing Capital (participant)Temasek (participant)HSG (participant)MPCi (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs”
Investors on record
5 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Dec 9, 2025
    D3 Bio announced Series B of $108,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company